CATALOGO DEI PRODOTTI DELLA RICERCA

RUGGIERO, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.947
EU - Europa 1.534
AS - Asia 1.508
SA - Sud America 263
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 48
OC - Oceania 2
Totale 5.386
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.889
RU - Federazione Russa 763
SG - Singapore 676
CN - Cina 244
IT - Italia 230
VN - Vietnam 224
BR - Brasile 213
HK - Hong Kong 139
GB - Regno Unito 101
FR - Francia 93
DE - Germania 81
SE - Svezia 73
IE - Irlanda 70
KR - Corea 62
ID - Indonesia 46
FI - Finlandia 38
BD - Bangladesh 28
CA - Canada 28
AR - Argentina 22
IN - India 21
NL - Olanda 18
IQ - Iraq 14
MX - Messico 14
AT - Austria 13
JP - Giappone 13
ES - Italia 10
BE - Belgio 9
NG - Nigeria 9
LT - Lituania 8
TG - Togo 8
TR - Turchia 8
VE - Venezuela 8
ZA - Sudafrica 7
UA - Ucraina 6
EC - Ecuador 5
MA - Marocco 5
PK - Pakistan 5
UZ - Uzbekistan 5
BJ - Benin 4
CO - Colombia 4
PL - Polonia 4
TN - Tunisia 4
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
PA - Panama 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
CY - Cipro 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SV - El Salvador 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 5.303
Salva come PNG Salva come JPEG
Città #
Dallas 415
Singapore 339
Moscow 248
San Jose 236
Chandler 213
Ashburn 204
Hong Kong 136
Council Bluffs 85
Verona 79
Dublin 68
Southend 68
The Dalles 60
Ho Chi Minh City 58
Beijing 54
Jakarta 38
Dong Ket 36
Hanoi 36
Los Angeles 36
Lawrence 32
New York 32
Princeton 32
Sindelfingen 30
Lappeenranta 26
Rome 23
Santa Clara 23
Columbus 22
Redondo Beach 22
Milan 21
Seoul 21
Jacksonville 20
Seattle 18
Buffalo 17
São Paulo 16
Nuremberg 14
Tokyo 13
Wilmington 13
Munich 12
Woodbridge 12
Ann Arbor 11
London 10
Toronto 10
Abuja 9
Da Nang 9
Frankfurt am Main 9
Brasília 8
Guangzhou 8
Lomé 8
Mexico City 8
Vienna 8
Montreal 7
Norwalk 7
Redmond 7
Baghdad 6
Bangalore 6
Brussels 6
Haiphong 6
Johannesburg 6
Phoenix 6
Rio de Janeiro 6
Salvador 6
Amsterdam 5
Boardman 5
Buttapietra 5
Chennai 5
Dongguan 5
Helsinki 5
Houston 5
Madrid 5
Orem 5
San Francisco 5
Tashkent 5
Thái Nguyên 5
Tianjin 5
Atlanta 4
Belo Horizonte 4
Brescia 4
Buenos Aires 4
Chicago 4
Cotonou 4
Des Moines 4
Guarulhos 4
Limeira 4
Ottawa 4
Shenyang 4
Walsall 4
Biên Hòa 3
Brooklyn 3
Campinas 3
Cincinnati 3
Genoa 3
Hangzhou 3
Helena 3
Istanbul 3
Kent 3
Mauá 3
Nanjing 3
Paris 3
San José 3
San Mateo 3
Santo André 3
Totale 3.153
Salva come PNG Salva come JPEG
Nome #
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines 368
HLA-C presence increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41 248
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 243
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 188
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 149
Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2 145
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine 144
Increased prevalence of unstable HLA-C variants in HIV-1 rapid-progressor patients 143
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy 132
Blood CXCR3+ CD4 T cells are enriched in inducible replication competent HIV in aviremic antiretroviral therapy-treated individuals 128
Comparative analysis and generation of a robust HIV-1 DNA quantification assay 127
Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children 126
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) 125
Factors associated with persistence of plasma HIV-1 RNA during long-term continuously suppressive firstline antiretroviral therapy 121
Clinical, virological and immunological subphenotypes in a cohort of early treated HIV-infected children 116
Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children 116
During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ 116
BNT162B2 mRNA COVID-19 vaccine in heart and lung transplanted young adults: is an alternative SARS-CoV-2 immune response surveillance needed? 115
Pseudotyped viruses as a molecular tool to monitor humoral immune responses against SARS-CoV-2 via neutralization assay 113
HIV and SARS-CoV-2 co-infection: from population study evidence to in vitro studies 112
Highly specific memory B cells generation after the 2nd dose of BNT162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal IgA 108
A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection 105
Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring 105
Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers 103
Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART 103
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia 101
Generation of liposomes to study the effect of Mycobacterium Tuberculosis lipids on HIV-1 cis- and trans-infections 100
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 98
The immunology of Multisystem Inflammatory Syndrome in children with COVID-19 96
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 92
OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines 92
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 87
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 85
Targeted protein degradation tools: overview and future perspectives 85
The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa' by Lemoine et al 83
The HCV envelope glycoprotein down-modulates NF-κB signalling and associates with stimulation of the host endoplasmic reticulum stress pathway 83
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana 79
Measuring proviral HIV-1 DNA: hurdles and improvements to an assay monitoring integration events utilising human Alu repeat sequences 79
Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection 76
Measuring the success of HIV-1 cure strategies 73
Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology 73
Utility of integrated HIV-1 DNA quantification in cure studies 69
Size of HIV-1 reservoir is associated with telomere shortening and immunosenescence in early-treated European children with perinatally acquired HIV-1 69
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment 54
CRISPR/Cas9 generation of HADHA KO PANC-1 cells to study the role of HADHA in pancreatic cancer stemness 54
Post-Translational Modifications in Respiratory Virus Infection: Recent Insights into the Development of In Vitro Models 34
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 32
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 29
CRISPR/Cas9-mediated generation of HADHA KO PANC-1 cells to study the role of HADHA in pancreatic cancer stemness 26
The absence of the human thioesterase ACOT8 negatively affects HIV-1 infectivity in vitro 26
Regulation of Tau Alternative Splicing: A Novel Role for the Ribonucleoprotein RBM20 10
High-Touch, High-Risk: An Exploratory Microbiome Analysis of Hospital Wheelchairs 2
Totale 5.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.473
article - articoli 19.197
book - libri 0
conference - conferenze 2.276
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022132 0 13 1 5 1 1 2 12 7 7 41 42
2022/2023600 42 63 55 96 46 130 10 40 82 9 18 9
2023/2024273 13 20 17 37 18 34 29 15 4 29 36 21
2024/2025999 44 52 35 193 25 41 86 59 161 64 65 174
2025/20262.988 189 140 461 396 630 175 268 161 237 210 41 80
2026/2027142 55 87 0 0 0 0 0 0 0 0 0 0
Totale 5.386